Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GDX vs MRNA✓SelectedUSD · MRNAGDX vs MRNA performance historyLatest closeAs of+0.79%11/17
Stock and ETF performance explorer

GDX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+329.7%
MRNA return
+840.0%
Excess return
-510.3%
Maximum drawdown
-49.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.8%-3.9%+4.7%+1.0%
7D-8.0%-17.6%+9.6%-6.8%
30D-9.3%-5.1%-4.1%-9.0%
3M-13.4%+220.8%-234.2%-23.6%
6M-8.9%+321.7%-330.6%-21.3%
YTD-7.2%+601.3%-608.5%-22.3%
1Y+6.9%+735.2%-728.3%-11.4%
3Y+189.9%+170.5%+19.4%+149.9%
5Y+146.8%-14.6%+161.4%+120.9%
All+329.7%+840.0%-510.3%+232.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling